Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media

References

• Tin Tin Htar M, van Den Biggelaar AHJ, Sings H, Ferreira G, Moffatt M, Hall-Murray C, Verstraeten T, Gessner BD, Schmitt H-J, Jodar L, et al. The impact of routine childhood immunization with higher-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal diseases and carriage: a systematic literature review. Expert Rev Vaccines. 2019;18(10):1069–18. doi:10.1080/14760584.2019.1676155.
   PubMed Web of Science ®Google Scholar
• Wiese AD, Griffin MR, Grijalva CG. Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States. Expert Rev Vaccines. 2019;18:327–41. doi:10.1080/14760584.2019.1582337.
   PubMed Web of Science ®Google Scholar
• Cohen R, Cohen JF, Chalumeau M, Levy C. Impact of pneumococcal conjugate vaccines for children in high- and non-high-income countries. Expert Rev Vaccines. 2017;16:625–40. doi:10.1080/14760584.2017.1320221.
   PubMed Web of Science ®Google Scholar
• Alicino C, Paganino C, Orsi A, Astengo M, Trucchi C, Icardi G, Ansaldi F. The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: a systematic review and meta-analysis. Vaccine. 2017;35:5776–85. doi:10.1016/j.vaccine.2017.09.005.
   PubMed Web of Science ®Google Scholar
• Buckley BS, Henschke N, Bergman H, Skidmore B, Klemm EJ, Villanueva G, Garritty C, Paul M. Impact of vaccination on antibiotic usage: a systematic review and meta-analysis. Clin Microbiol Infect. 2019;25:1213–25. doi:10.1016/j.cmi.2019.06.030.
   PubMed Web of Science ®Google Scholar
• de Oliveira LH, Shioda K, Valenzuela MT, Janusz CB, Rearte A, Sbarra AN, Warren JL, Toscano CM, Weinberger DM. Declines in pneumonia mortality following the introduction of pneumococcal conjugate vaccines in Latin American and Caribbean countries. Clin Infect Dis. 2021;73(2):306–13. doi:10.1093/cid/ciaa614.
   PubMed Web of Science ®Google Scholar
• Tsaban G, Ben-Shimol S. Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: a systematic review of the literature. Vaccine. 2017;35:2882–91. doi:10.1016/j.vaccine.2017.04.032.
   PubMed Web of Science ®Google Scholar
• Loo JD, Conklin L, Fleming-Dutra KE, Knoll MD, Park DE, Kirk J, Goldblatt D, O’Brien KL, Whitney CG. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization. Pediatr Infect Dis J. 2014;33(Suppl 2):S161–71. doi:10.1097/INF.0000000000000084.
   PubMed Web of Science ®Google Scholar
• Berman-Rosa M, O’Donnell S, Barker M, Quach C. Efficacy and effectiveness of the PCV-10 and PCV-13 vaccines against invasive pneumococcal disease. Pediatrics. 2020;145:e20190377. doi:10.1542/peds.2019-0377.
   PubMed Web of Science ®Google Scholar
• Izurieta P, Bahety P, Adegbola R, Clarke C, Hoet B. Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution. Expert Rev Vaccines. 2018;17:479–93. doi:10.1080/14760584.2018.1413354.
   PubMed Web of Science ®Google Scholar
• Vojtek I, Nordgren M, Hoet B. Impact of pneumococcal conjugate vaccines on otitis media: a review of measurement and interpretation challenges. Int J Pediatr Otorhinolaryngol. 2017;100:174–82. doi:10.1016/j.ijporl.2017.07.009.
   PubMed Web of Science ®Google Scholar
• Newhouse, L. PATH new pneumococcal vaccine from Serum Institute of India achieves WHO prequalification. 2019 Dec 19 [accessed 2020 Aug 21]. https://www.path.org/media-center/new-pneumococcal-vaccine-serum-institute-india-achieves-who-prequalification/
   Google Scholar
• de Oliveira LH, Camacho LA, Coutinho ESF, Martinez-Silveira MS, Carvalho AF, Ruiz-Matus C, Toscano CM. Impact and effectiveness of 10 and 13-valent pneumococcal conjugate vaccines on hospitalization and mortality in children aged less than 5 years in Latin American countries: a systematic review. PLoS One. 2016;11(12):e0166736. doi:10.1371/journal.pone.0166736.
   PubMed Web of Science ®Google Scholar
• Cohen O, Knoll M, O’Brien K, Ramakrishnan M, Constenla D, Privor-Dumm L, Buss-Younkin J, Farrar J, Pilishvili T, Whitney C. Pneumococcal conjugate vaccine (PCV) product assessment 2017 April. [accessed 2020 Jul 10]. https://www.jhsph.edu/ivac/wp-content/uploads/2018/05/pcv-product-assessment-april-25-2017.pdf.
   Google Scholar
• McGirr A, Iqbal SM, Izurieta P, Talarico C, Luijken J, Redig J, Newson RS. A systematic literature review and network meta-analysis feasibility study to assess the comparative efficacy and comparative effectiveness of pneumococcal conjugate vaccines. Hum Vaccin Immunother. 2019;15(11):2713–24. doi:10.1080/21645515.2019.1612667.
   PubMed Web of Science ®Google Scholar
• O’Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374(9693):893–902. doi:10.1016/S0140-6736(09)61204-6.
   PubMed Web of Science ®Google Scholar
• Fortanier AC, Venekamp RP, Boonacker CW, Hak E, Schilder AG, Sanders EA, Damoiseaux RA. Pneumococcal conjugate vaccines for preventing acute otitis media in children. Cochrane Database Syst Rev. 2019;5:Cd001480. doi:10.1002/14651858.CD001480.pub5.
   PubMed Web of Science ®Google Scholar
• Leibovitz E, Jacobs MR, Dagan R. Haemophilus influenzae: a significant pathogen in acute otitis media. Pediatr Infect Dis J. 2004;23:1142–52.
   PubMed Web of Science ®Google Scholar
• Clarke C, Bakaletz LO, Ruiz-Guinazu J, Borys D, Mrkvan T. Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage. Expert Rev Vaccines. 2017;16:1–14. doi:10.1080/14760584.2017.1333905.
   PubMed Web of Science ®Google Scholar
• Saez-Llorens X, Rowley S, Wong D, Rodriguez M, Calvo A, Troitino M, Salas A, Vega V, Castrejón MM, Lommel P. Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children – a randomized controlled trial. Hum Vaccin Immunother. 2017;13:1–16. doi:10.1080/21645515.2017.1287640.
   PubMed Web of Science ®Google Scholar
• Tregnaghi MW, Saez-Llorens X, Lopez P, Abate H, Smith E, Posleman A, Calvo A, Wong D, Cortes-Barbosa C, Ceballos A, et al. Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: a double-blind randomized controlled trial. PLoS Med. 2014;11(6):e1001657. doi:10.1371/journal.pmed.1001657.
   PubMed Web of Science ®Google Scholar
• Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Herva E, Takala A, Käyhty H, Karma P, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403–09. doi:10.1056/NEJM200102083440602.
   PubMed Web of Science ®Google Scholar
• Palmu AA, Jokinen J, Nieminen H, Rinta-Kokko H, Ruokokoski E, Puumalainen T, Moreira M, Schuerman L, Borys D, Kilpi TM, et al. Vaccine-preventable disease incidence of pneumococcal conjugate vaccine in the Finnish invasive pneumococcal disease vaccine trial. Vaccine. 2018;36(14):1816–22. doi:10.1016/j.vaccine.2018.02.088.
   PubMed Web of Science ®Google Scholar
• de Sevaux JL, Venekamp RP, Lutje V, Hak E, Schilder AG, Sanders EA, Damoiseaux RA. Pneumococcal conjugate vaccines for preventing acute otitis media in children. Cochrane Database Syst Rev. 2020;11:CD001480. doi:10.1002/14651858.CD001480.pub6.
   PubMedGoogle Scholar
• Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5:210. doi:10.1186/s13643-016-0384-4.
   PubMed Web of Science ®Google Scholar
• Sterne JAC, Hernán MA, McAleenan A, Reeves BC, Higgins JPT. Chapter 25: assessing risk of bias in a non-randomized study. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane handbook for systematic reviews of interventions version 6.0 (updated July 2019). Cochrane; 2019. https://methods.cochrane.org/methods-cochrane/robins-i-tool.
   Google Scholar
• Higgins JPT, Savović J, Page MJ, Elbers RG, Sterne JAC. Chapter 8: assessing risk of bias in a randomized trial. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane handbook for systematic reviews of interventions version 6.0 (updated July 2019). Cochrane; 2019. https://methods.cochrane.org/risk-bias-2.
   Google Scholar
• Palmu AA, Jokinen J, Nieminen H, Rinta-Kokko H, Ruokokoski E, Puumalainen T, Traskine M, Moreira M, Borys D, Schuerman L. Effectiveness of the ten-valent pneumococcal conjugate vaccine against tympanostomy tube placements in a cluster-randomized trial. Pediatr Infect Dis J. 2015;34(11):1230–35. doi:10.1097/inf.0000000000000857.
   PubMed Web of Science ®Google Scholar
• Karppinen S, Toivonen L, Schuez-Havupalo L, Teros-Jaakkola T, Waris M, Auranen K, Palmu AA, Peltola V. Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against all respiratory tract infections in children under two years of age. Vaccine. 2019;37:2935–41. doi:10.1016/j.vaccine.2019.04.026.
   PubMed Web of Science ®Google Scholar
• Pichichero M, Kaur R, Scott DA, Gruber WC, Trammel J, Almudevar A, Center KJ. Effectiveness of 13-valent pneumococcal conjugate vaccination for protection against acute otitis media caused by Streptococcus pneumoniae in healthy young children: a prospective observational study. Lancet Child Adolesc Health. 2018;2(8):561–68. doi:10.1016/s2352-4642(18)30168-8.
   PubMedGoogle Scholar
• Ochoa-Gondar O, Figuerola-Massana E, Vila-Corcoles A, Aguirre CA, de Diego C, Satue E, Gomez F, Raga X. Epidemiology of Streptococcus pneumoniae causing acute otitis media among children in Southern Catalonia throughout 2007-2013: incidence, serotype distribution and vaccine’s effectiveness. Int J Pediatr Otorhinolaryngol. 2015;79:2104–08. doi:10.1016/j.ijporl.2015.09.022.
   PubMed Web of Science ®Google Scholar
• Sohn S, Hong K, Chun BC. Evaluation of the effectiveness of pneumococcal conjugate vaccine for children in Korea with high vaccine coverage using a propensity score matched national population cohort. Int J Infect Dis. 2020;93:146–50. doi:10.1016/j.ijid.2020.01.034.
   PubMed Web of Science ®Google Scholar
• Lau WC, Murray M, El-Turki A, Saxena S, Ladhani S, Long P, Sharland M, Wong ICK, Hsia Y. Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom. Vaccine. 2015;33(39):5072–79. doi:10.1016/j.vaccine.2015.08.022.
   PubMed Web of Science ®Google Scholar
• Wiese AD, Huang X, Yu C, Mitchel EF, Kyaw MH, Griffin MR, Grijalva CG. Changes in otitis media episodes and pressure equalization tube insertions among young children following introduction of the 13-valent pneumococcal conjugate vaccine: a birth-cohort based study. Clin Infect Dis. 2019;69:2162–69. doi:10.1093/cid/ciz142.
   PubMed Web of Science ®Google Scholar
• Zhou X, de Luise C, Gaffney M, Burt CW, Scott DA, Gatto N, Center KJ. National impact of 13-valent pneumococcal conjugate vaccine on ambulatory care visits for otitis media in children under 5 years in the United States. Int J Pediatr Otorhinolaryngol. 2019;119:96–102. doi:10.1016/j.ijporl.2019.01.023.
   PubMed Web of Science ®Google Scholar
• Kawai K, Adil EA, Barrett D, Manganella J, Kenna MA. Ambulatory visits for otitis media before and after the introduction of pneumococcal conjugate vaccination. J Pediatr. 2018;201:122–127.e1. doi:10.1016/j.jpeds.2018.05.047.
   PubMed Web of Science ®Google Scholar
• Fortanier AC, Venekamp RP, Hoes AW, Schilder AGM. Does pneumococcal conjugate vaccination affect onset and risk of first acute otitis media and recurrences? A primary care-based cohort study. Vaccine. 2019;37:1528–32. doi:10.1016/j.vaccine.2019.01.064.
   PubMed Web of Science ®Google Scholar
• Sigurdsson S, Eythorsson E, Hrafnkelsson B, Erlendsdottir H, Kristinsson KG, Haraldsson A. Reduction in all-cause acute otitis media in children <3 years of age in primary care following vaccination with 10-valent pneumococcal haemophilus influenzae protein-D conjugate vaccine: a whole-population study. Clin Infect Dis. 2018;67:1213–19. doi:10.1093/cid/ciy233.
   PubMed Web of Science ®Google Scholar
• Sartori AL, Minamisava R, Bierrenbach AL, Toscano CM, Afonso ET, Morais-Neto OL, Antunes JLF, Cristo EB, Andrade AL. Reduction in all-cause otitis media-related outpatient visits in children after PCV10 introduction in Brazil. PLoS One. 2017;12(6):e0179222. doi:10.1371/journal.pone.0179222.
   PubMed Web of Science ®Google Scholar
• Rosenblut A, Rosenblut M, Garcia K, Maul X, Santolaya ME. Frequency of acute otitis media in children under 24 months of age before and after the introduction of the 10-valent pneumococcal conjugate vaccine into the national immunization program in Chile. Pediatr Infect Dis J. 2018;37:132–34. doi:10.1097/inf.0000000000001722.
   PubMed Web of Science ®Google Scholar
• Suarez V, Michel F, Toscano CM, Bierrenbach AL, Gonzales M, Alencar AP, Ruiz Matus C, Andrus JK, de Oliveira LH. Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: time series analyses. Vaccine. 2016;34:4738–43. doi:10.1016/j.vaccine.2016.07.027.
   PubMed Web of Science ®Google Scholar
• Marom T, Bookstein Peretz S, Schwartz O, Goldfarb A, Oron Y, Tamir SO. Impact of pneumococcal conjugate vaccines on selected head and neck infections in hospitalized Israeli children. Pediatr Infect Dis J. 2017;36:314–18. doi:10.1097/inf.0000000000001425.
   PubMed Web of Science ®Google Scholar
• Laursen BB, Danstrup CS, Hoffmann S, Norskov-Lauritsen N, Christensen ALB, Ovesen T. The effect of pneumococcal conjugate vaccines on incidence and microbiology associated with complicated acute otitis media. Int J Pediatr Otorhinolaryngol. 2017;101:249–53. doi:10.1016/j.ijporl.2017.07.002.
   PubMed Web of Science ®Google Scholar
• Tawfik KO, Ishman SL, Altaye M, Meinzen-Derr J, Choo DI. Pediatric acute otitis media in the era of pneumococcal vaccination. Otolaryngol Head Neck Surg. 2017;156:938–45. doi:10.1177/0194599817699599.
   PubMed Web of Science ®Google Scholar
• Fortunato F, Martinelli D, Cappelli MG, Cozza V, Prato R. Impact of pneumococcal conjugate universal routine vaccination on pneumococcal disease in Italian children. J Immunol Res. 2015;2015:206757. doi:10.1155/2015/206757.
   PubMed Web of Science ®Google Scholar
• Leach AJ, Wigger C, Andrews R, Chatfield M, Smith-Vaughan H, Morris PS. Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules. BMC Pediatr. 2014;14:200. doi:10.1186/1471-2431-14-200.
   PubMed Web of Science ®Google Scholar
• Sigurdsson S, Eythorsson E, Erlendsdottir H, Hrafnkelsson B, Kristinsson KG, Haraldsson A. Impact of the 10-valent pneumococcal conjugate vaccine on hospital admissions in children under three years of age in Iceland. Vaccine. 2020;38:2707–14. doi:10.1016/j.vaccine.2020.01.094.
   PubMed Web of Science ®Google Scholar
• Petousis-Harris H, Howe AS, Paynter J, Turner N, Griffin J. Pneumococcal conjugate vaccines turning the tide on inequity: a retrospective cohort study of New Zealand children born 2006-2015. Clin Infect Dis. 2019;68:818–26. doi:10.1093/cid/ciy570.
   PubMed Web of Science ®Google Scholar
• Ben-Shimol S, Givon-Lavi N, Leibovitz E, Greenberg D, Dagan R. Studying PCV impact on clinical presentation of otitis media helps to understand its pathogenesis. Vaccine. 2019;37:1–6. doi:10.1016/j.vaccine.2018.11.054.
   PubMed Web of Science ®Google Scholar
• Ben-Shimol S, Givon-Lavi N, Leibovitz E, Raiz S, Greenberg D, Dagan R. Impact of widespread introduction of pneumococcal conjugate vaccines on pneumococcal and nonpneumococcal otitis media. Clin Infect Dis. 2016;63:611–18. doi:10.1093/cid/ciw347.
   PubMed Web of Science ®Google Scholar
• Ben-Shimol S, Givon-Lavi N, Leibovitz E, Raiz S, Greenberg D, Dagan R. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV. Clin Infect Dis. 2014;59:1724–32. doi:10.1093/cid/ciu683.
   PubMed Web of Science ®Google Scholar
• Palmu AA, Rinta-Kokko H, Nohynek H, Nuorti JP, Jokinen J. Impact of national ten-valent pneumococcal conjugate vaccine program on reducing antimicrobial use and tympanostomy tube placements in Finland. Pediatr Infect Dis J. 2018;37:97–102. doi:10.1097/inf.0000000000001810.
   PubMed Web of Science ®Google Scholar
• Eythorsson E, Sigurdsson S, Erlendsdottir H, Hrafnkelsson B, Kristinsson KG, Haraldsson A. Increase in tympanostomy tube placements despite pneumococcal vaccination, a population-based study. Acta Paediatr. 2019;108:1527–34. doi:10.1111/apa.14724.
   PubMed Web of Science ®Google Scholar
• Gisselsson-Solen M. Trends in otitis media incidence after conjugate pneumococcal vaccination: a national observational study. Pediatr Infect Dis J. 2017;36:1027–31. doi:10.1097/inf.0000000000001654.
   PubMed Web of Science ®Google Scholar
• Edmondson-Jones M, Dibbern T, Hultberg M, Anell B, Medin E, Feng Y, Talarico C. The effect of pneumococcal conjugate vaccines on otitis media from 2005 to 2013 in children aged ≤5 years: a retrospective cohort study in two Swedish regions. Hum Vaccin Immunother. 2021;17:517–26. doi:10.1080/21645515.2020.1775455.
   PubMed Web of Science ®Google Scholar
• Leach AJ, Wigger C, Beissbarth J, Woltring D, Andrews R, Chatfield MD, Smith-Vaughan H, Morris PS. General health, otitis media, nasopharyngeal carriage and middle ear microbiology in northern territory aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines. Int J Pediatr Otorhinolaryngol. 2016;86:224–32. doi:10.1016/j.ijporl.2016.05.011.
   PubMed Web of Science ®Google Scholar
• Lee J, Kim KH, Jo DS, Ma SH, Kim JH, Kim CS, Kim HM, Kang JH. A longitudinal hospital-based epidemiology study to assess acute otitis media incidence and nasopharyngeal carriage in Korean children up to 24 months. Hum Vaccin Immunother. 2020;16:3090–97. doi:10.1080/21645515.2020.1748978.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Forsten A, Seppa I, Kaijalainen T, Puumalainen T, Soininen A, Traskine M, Lommel P, Schoonbroodt S, Hezareh M, et al. Effectiveness of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D–conjugated vaccine (PHiD-CV) against carriage and acute otitis media – a double-blind randomized clinical trial in Finland. J Pediatr Infect Dis Soc. 2016;5:237–48. doi:10.1093/jpids/piw010.
   PubMed Web of Science ®Google Scholar
• Eythorsson E, Sigurdsson S, Hrafnkelsson B, Erlendsdottir H, Haraldsson A, Kristinsson KG. Impact of the 10-valent pneumococcal conjugate vaccine on antimicrobial prescriptions in young children: a whole population study. BMC Infect Dis. 2018;18:505. doi:10.1186/s12879-018-3416-y.
   PubMed Web of Science ®Google Scholar
• Eythorsson E, Hrafnkelsson B, Erlendsdottir H, Gudmundsson SA, Kristinsson KG, Haraldsson A. Decreased acute otitis media with treatment failure after introduction of the ten-valent pneumococcal Haemophilus influenzae Protein D conjugate vaccine. Pediatr Infect Dis J. 2018;37:361–66. doi:10.1097/inf.0000000000001870.
   PubMed Web of Science ®Google Scholar
• Kong K, Coates HL. Natural history, definitions, risk factors and burden of otitis media. Med J Aust. 2009;191:S39–43. doi:10.5694/j.1326-5377.2009.tb02925.x.
   PubMed Web of Science ®Google Scholar
• Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, Kohl I, Lommel P, Poolman J, Prieels JP, Schuerman L. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet. 2006;367:740–48. doi:10.1016/S0140-6736(06)68304-9.
   PubMed Web of Science ®Google Scholar
• Fletcher MA, Fritzell B. Pneumococcal conjugate vaccines and otitis media: an appraisal of the clinical trials. Int J Otolaryngol. 2012;2012:312935. doi:10.1155/2012/312935.
   PubMedGoogle Scholar
• Griffiths UK, Clark A, Gessner B, Miners A, Sanderson C, Sedyaningsih ER, Mulholland KE. Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: a systematic review and meta-analysis of controlled clinical trials. Epidemiol Infect. 2012;140:1343–55. doi:10.1017/S0950268812000957.
   PubMed Web of Science ®Google Scholar
• Monasta L, Ronfani L, Marchetti F, Montico M, Vecchi Brumatti L, Bavcar A, Grasso D, Barbiero C, Tamburlini G. Burden of disease caused by otitis media: systematic review and global estimates. PLoS One. 2012;7:e36226. doi:10.1371/journal.pone.0036226.
   PubMed Web of Science ®Google Scholar
• Alderson MR. Status of research and development of pediatric vaccines for Streptococcus pneumoniae. Vaccine. 2016;34:2959–61. doi:10.1016/j.vaccine.2016.03.107.
   PubMed Web of Science ®Google Scholar
• Balsells E, Guillot L, Nair H, Kyaw MH. Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: a systematic review and meta-analysis. PLoS One. 2017;12:e0177113. doi:10.1371/journal.pone.0177113.
   PubMed Web of Science ®Google Scholar
• Lagousi T, Basdeki P, Routsias J, Spoulou V. Novel protein-based pneumococcal vaccines: assessing the use of distinct protein fragments instead of full-length proteins as vaccine antigens. Vaccines (Basel). 2019;7:9. doi:10.3390/vaccines7010009.
   PubMed Web of Science ®Google Scholar
• Borrow R, Dagan R, Zepp F, Hallander H, Poolman J. Glycoconjugate vaccines and immune interactions, and implications for vaccination schedules. Expert Rev Vaccines. 2011;10:1621–31. doi:10.1586/erv.11.142.
   PubMed Web of Science ®Google Scholar